Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher's Q4 Sales Surge 126 Percent, Though Profits Tumble My More Than Half

This update includes a $125-million charge related to the Thermo-Fisher merger, which negatively affected fourth-quarter 2006 profit.
 
NEW YORK (GenomeWeb News) — Thermo Fisher Scientific today said fourth-quarter revenues increased 126 percent as R&D spending rose 36 percent and profit declined by more than half on merger-related charges.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $1.67 billion from $741 million year over year.
 
Thermo said revenue from its Analytical Technologies segment increased 57 percent to $849 million, while receipts from the Lab Products and Services segment increased 330 percent to $861 million.
 
R&D spending increased to $52.1 million from $38.2 million in the fourth quarter of 2005.
 
The company said profit declined to $25.3 million from $56.4 million in the year-ago period. The current quarter's profits includes a $125-million charge related to the Thermo-Fisher merger.
 
Thermo said it had around $667 million in cash and equivalents and $23.8 million in short-term investments as of Dec. 31, 2006.
 
Thermo Fisher Scientific was created in the fourth quarter when Thermo Electron and Fisher Scientific completed their $10.6 billion merger.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.